Epidemiology Practice Questions

Q: What is the most common cause of death in developed countries?

Ischemic heart disease. **Explanation:** **Correct Answer: A. Ischemic Heart Disease (IHD)** In developed countries, the epidemiological transition has shifted the burden of disease from communicable to non-communicable diseases (NCDs). Ischemic Heart Disease (also known as Coronary Artery Disease) is currently the leading cause of mortality globally and specifically in developed nations. This is attributed to increased life expectancy, sedentary lifestyles, and high prevalence of metabolic risk factors such as hypertension, hyperlipidemia, and obesity. According to the WHO Global Health Estimates, IHD remains the "World’s Biggest Killer," accounting for approximately 16% of total deaths worldwide. **Analysis of Incorrect Options:** * **B. Accidents:** While road traffic accidents (RTAs) and unintentional injuries are a significant cause of death among the younger population (ages 15–29), they do not surpass the total mortality rate of cardiovascular diseases in the general population of developed countries. * **C. Infectious disease:** These were the leading cause of death historically. However, due to advancements in sanitation, immunization, and antibiotics, infectious diseases now account for a much smaller fraction of mortality in developed nations compared to developing or low-income countries. **High-Yield Clinical Pearls for NEET-PG:** * **Global Burden:** IHD is the #1 cause of death worldwide. * **Developing Countries:** While infectious diseases are still prevalent, NCDs (led by IHD) are rapidly becoming the leading cause of death here as well (Double Burden of Disease). * **Most Common Cancer Death:** Globally, Lung Cancer is the leading cause of cancer-related mortality in both developed and developing regions. * **Leading Disability-Adjusted Life Years (DALYs):** IHD is also a top contributor to the global DALYs.

Q: In the natural history of disease, all are true about the period of pathogenesis, EXCEPT:

Screening does not affect the course of the phase. In the natural history of disease, the **Pathogenesis Phase** begins the moment the disease agent enters a susceptible human host. ### Why Option C is the Correct Answer (The Exception) Screening is a core component of **Secondary Prevention**. Its primary objective is the early detection of disease during the sub-clinical or early symptomatic stage of the pathogenesis phase. By identifying the disease early, medical intervention can halt the progression, prevent complications, and significantly alter the clinical course. Therefore, stating that screening "does not affect the course" is factually incorrect. ### Analysis of Other Options * **A. Occurs after the agent enters the host body:** This is the definition of pathogenesis. It contrasts with the *Pre-pathogenesis phase*, where the agent, host, and environment exist but have not yet interacted within the human body. * **B. Tertiary prevention is possible at this stage:** Tertiary prevention (disability limitation and rehabilitation) occurs during the late stages of pathogenesis to reduce the impact of long-term disease or permanent impairment. * **C. A sub-clinical phase can be present:** Pathogenesis is divided into the **pre-symptomatic (sub-clinical)** phase, where physiological changes occur without visible symptoms, and the **clinical phase**, where signs and symptoms appear. ### NEET-PG High-Yield Pearls * **Pre-pathogenesis:** Corresponds to **Primary Prevention** (Health promotion and Specific protection). * **Pathogenesis:** Corresponds to **Secondary Prevention** (Early diagnosis and Treatment) and **Tertiary Prevention**. * **Biological Onset:** The exact point where pathogenesis begins; often occurs long before the "Clinical Horizon" (the point where symptoms become manifest). * **Screening:** Aims to shift the diagnosis to the left of the clinical horizon.

Q: Urban malaria is caused by which of the following mosquitoes?

Anopheles stephensi. **Explanation:** The correct answer is **Anopheles stephensi**. In India, the epidemiology of malaria is largely defined by the specific breeding habits of its vectors. **Why Anopheles stephensi is correct:** *Anopheles stephensi* is the primary vector for **Urban Malaria**. It has adapted to urban environments by breeding in artificial containers, overhead water tanks, cisterns, fountain basins, and construction sites. Its ability to thrive in clean, stagnant water found in man-made structures makes it the dominant vector in cities. **Analysis of Incorrect Options:** * **A. Anopheles culicifacies:** This is the most important vector for **Rural Malaria** in India. It breeds in rainwater pools, irrigation channels, and borrow pits. It is responsible for nearly 60-70% of total malaria cases in the country, primarily in rural settings. * **B. Phlebotomus:** This is the Sandfly, which is the vector for **Kala-azar** (Visceral Leishmaniasis) and Oriental Sore, not malaria. * **C. Aedes:** *Aedes aegypti* and *Aedes albopictus* are vectors for **Dengue, Chikungunya, and Zika virus**. They are "day-biters" and breed in artificial containers, but they do not transmit malaria. **High-Yield Clinical Pearls for NEET-PG:** * **Major Vectors in India:** * **Rural:** *An. culicifacies* * **Urban:** *An. stephensi* * **Hills/Forests:** *An. fluviatilis* * **North-East India:** *An. minimus* and *An. dirus* * **Urban Malaria Scheme (UMS):** Launched in 1971, it focuses on anti-larval measures (source reduction) because urban vectors breed in accessible man-made containers. * **Feeding Habit:** Most Anopheles mosquitoes are **nocturnal** (night-biters), whereas Aedes are diurnal.

Q: A study surveyed 3500 patients with thyroid cancer regarding their past exposure to radiation. The study design most appropriately illustrates which of the following?

Case series report. **Explanation:** The correct answer is **Case series report (Option A)**. In this scenario, the researchers are looking at a group of 3500 patients who already have the disease (thyroid cancer) and are documenting their history of exposure. A **Case Series** is a descriptive study design that describes the characteristics of a group of individuals with a common disease or exposure. It does not utilize a control group, making it purely descriptive rather than analytical. **Why other options are incorrect:** * **Case-control study (B):** This requires a **comparison group** (controls) of people without thyroid cancer to compare the frequency of radiation exposure. Since no control group is mentioned, it cannot be a case-control study. * **Case report (C):** A case report describes a single patient or a very small number of patients (usually <10) with a unique or unusual presentation. A sample size of 3500 is far too large for a case report. * **Clinical trial (D):** This is an interventional study where the researcher assigns an exposure (like a drug). In this scenario, the exposure (radiation) happened in the past, and the study is observational. **Clinical Pearls for NEET-PG:** * **Hierarchy of Evidence:** Case reports and case series are at the bottom of the evidence pyramid because they lack a control group. * **Key Identifier:** If a question describes a group of diseased individuals without a comparison group, it is a **Case Series**. * **Utility:** Case series are excellent for identifying the emergence of new diseases or rare side effects but cannot prove **causality** or calculate **Relative Risk/Odds Ratio**. * **Directionality:** Case series are retrospective in nature (looking back at history/records).

Q: Study of time, place, and person is called as?

Descriptive epidemiology. ### Explanation **1. Why Descriptive Epidemiology is Correct:** Descriptive epidemiology is the first step in an epidemiological investigation. It focuses on describing the occurrence and distribution of a disease in a population. It answers the fundamental questions of **Who** (Person), **Where** (Place), and **When** (Time). * **Time:** Trends, seasonal variations, or cyclic patterns. * **Place:** Geographic distribution (urban vs. rural, local vs. international). * **Person:** Characteristics like age, sex, occupation, and socio-economic status. The primary outcome of descriptive epidemiology is the **formulation of a hypothesis**. **2. Why Other Options are Incorrect:** * **Analytical Epidemiology (Option B):** This step goes beyond description to test the hypothesis formulated in descriptive studies. It focuses on the **"Why"** and **"How"** (determinants) by comparing a study group with a control group (e.g., Case-control or Cohort studies). * **Experimental Epidemiology (Option A):** This involves the deliberate manipulation of the study factor (e.g., giving a drug vs. a placebo) to confirm the etiology of a disease or the efficacy of a treatment. * **Randomized Controlled Trial (Option D):** This is a specific type of experimental study design, often considered the "gold standard" for testing new interventions. It is a subset of experimental epidemiology, not a study of time, place, and person. **3. High-Yield Clinical Pearls for NEET-PG:** * **Sequence of Epidemiology:** Descriptive (Hypothesis formulation) → Analytical (Hypothesis testing) → Experimental (Hypothesis confirmation). * **The Epidemiological Triad:** Agent, Host, and Environment (distinct from the "Time, Place, Person" triad). * **Key Metric:** Descriptive epidemiology often uses **Prevalence**, while Analytical epidemiology (specifically Cohort studies) measures **Incidence**.

Q: Which of the following is NOT included in the 'SAFE' strategy?

Supplementation of vitamins. The **SAFE strategy** is a comprehensive public health approach recommended by the World Health Organization (WHO) for the elimination of **Trachoma**, the leading infectious cause of blindness worldwide. ### **Why "Supplementation of vitamins" is the correct answer:** Vitamin supplementation (specifically Vitamin A) is a core strategy for preventing Xerophthalmia and nutritional blindness, but it is **not** a component of the SAFE strategy. Trachoma is caused by *Chlamydia trachomatis* (serotypes A, B, Ba, and C), and its management focuses on surgical intervention, infection control, and hygiene rather than nutritional support. ### **Explanation of the SAFE Components:** * **S - Surgery:** To treat the blinding stage of the disease (Trachomatous Trichiasis) by correcting inward-turning eyelashes. * **A - Antibiotics:** Specifically the use of **Azithromycin** (single oral dose) or Tetracycline eye ointment to treat the active infection and reduce the community reservoir. * **F - Facial cleanliness:** Encouraging regular face washing, especially in children, to reduce the transmission of infected ocular and nasal secretions. * **E - Environmental improvement:** Improving access to water and sanitation (e.g., latrine construction) to reduce the population of **Musca sorbens** (eye-seeking flies) that act as vectors. ### **High-Yield Facts for NEET-PG:** * **Target:** The WHO "GET2020" initiative aimed to eliminate trachoma by 2020. * **Vector:** The common housefly (*Musca domestica*) and the eye-seeking fly (*Musca sorbens*). * **Drug of Choice:** Azithromycin (20 mg/kg up to 1g). * **India Status:** India was declared free from **infective trachoma** in 2017, though surveillance for trichiasis continues.

Q: While analyzing data, allocation into similar groups is done to ensure what?

Comparability. ### Explanation **1. Why Comparability is Correct:** In epidemiological studies, particularly in **Randomized Controlled Trials (RCTs)** and **Case-Control studies**, the primary goal of allocation (randomization or matching) is to ensure that the study and control groups are as similar as possible in all respects except for the intervention or exposure being studied. This process ensures **Comparability**. When groups are comparable, any difference in the outcome can be confidently attributed to the intervention rather than to baseline differences or "confounding variables." **2. Analysis of Incorrect Options:** * **Accuracy:** Refers to how close a measurement is to the true value. While proper allocation reduces bias, accuracy is more closely related to the precision of instruments and data collection methods. * **Validity:** This is a broader term. While comparability contributes to *Internal Validity* (the degree to which the results are true for the study population), allocation itself is the specific mechanism used to achieve the prerequisite state of comparability. * **Sensitivity:** This is a measure of a screening or diagnostic test's ability to correctly identify those with the disease (True Positives). It is unrelated to the grouping of subjects in data analysis. **3. NEET-PG High-Yield Pearls:** * **Randomization** is the "heart" of an RCT because it eliminates **selection bias** and ensures comparability of both known and unknown confounders. * **Matching** is the technique used in Case-Control studies to ensure comparability between cases and controls. * **Confounding** occurs when the groups are *not* comparable, leading to a distortion of the true association between exposure and outcome. * **Blinding** is done to maintain the integrity of the study *after* allocation, whereas **Allocation** is done to ensure baseline similarity.

Q: What is the analysis of routine measurements aimed at detecting changes in the environment known as?

Monitoring. **Explanation:** **Why Monitoring is Correct:** Monitoring refers to the **performance and analysis of routine measurements** aimed at detecting changes in the environment or health status of a population. It is a continuous process that measures the performance of an activity to ensure it is proceeding according to plan. In environmental health, this involves tracking levels of pollutants (e.g., air quality index or water chlorine levels) to ensure they remain within safe limits. **Analysis of Incorrect Options:** * **Surveillance:** While often confused with monitoring, surveillance is the continuous **scrutiny** of all aspects of occurrence and spread of a disease that are pertinent to effective control. It is broader and involves data collection, analysis, and **action** (e.g., Integrated Disease Surveillance Programme). * **Isolation:** This is a clinical intervention where an infected individual is separated from others during the period of communicability to prevent the direct or indirect transmission of the infectious agent. * **Randomized Controlled Trial (RCT):** This is an analytical epidemiological study design used to test the efficacy of a new drug or intervention. It is not a routine measurement of the environment. **High-Yield Clinical Pearls for NEET-PG:** * **Monitoring vs. Surveillance:** Monitoring is a sub-component of surveillance. Monitoring tracks the *process*, while surveillance tracks the *outcome* and involves a feedback loop for action. * **Sentinel Surveillance:** A method used when notification data is silent; it identifies "missing cases" to estimate the total health problem in a community. * **Key Distinction:** If the question mentions "routine measurements" or "performance of an activity," think **Monitoring**. If it mentions "continuous scrutiny" or "distribution of disease," think **Surveillance**.

Question 1

What is the most common cause of death in developed countries?

Accepted Answer

Ischemic heart disease

Answer

Accidents

Answer

Infectious disease

Answer

None of the above

Question 2

In the natural history of disease, all are true about the period of pathogenesis, EXCEPT:

Accepted Answer

Screening does not affect the course of the phase

Answer

Occurs after the agent enters the host body

Answer

Tertiary prevention is possible at this stage

Answer

A sub-clinical phase can be present

Question 3

Urban malaria is caused by which of the following mosquitoes?

Accepted Answer

Anopheles stephensi

Answer

Anopheles culicifacies

Answer

Phlebotomus

Answer

Aedes

Question 4

A study surveyed 3500 patients with thyroid cancer regarding their past exposure to radiation. The study design most appropriately illustrates which of the following?

Accepted Answer

Case series report

Answer

Case control study

Answer

Case report

Answer

Clinical trial

Question 5

Study of time, place, and person is called as?

Accepted Answer

Descriptive epidemiology

Answer

Experimental epidemiology

Answer

Analytical epidemiology

Answer

Randomized controlled trial

Question 6

Which of the following is NOT included in the 'SAFE' strategy?

Accepted Answer

Supplementation of vitamins

Answer

Antibiotics

Answer

Face washing

Answer

Improvement of the environment

Question 7

In a prospective study comprising 10,000 subjects, 6000 subjects were assigned to receive beta carotene and 4000 were not. Three out of the 6000 subjects receiving beta carotene developed lung cancer, and two out of the 4000 subjects not receiving beta carotene developed lung cancer. What is the interpretation of these results?

Accepted Answer

Beta carotene and lung cancer have no statistically significant relation.

Answer

Beta carotene is protective against lung cancer.

Answer

The study design is not sufficient to draw any meaningful conclusions.

Answer

Beta carotene is carcinogenic.

Question 8

While analyzing data, allocation into similar groups is done to ensure what?

Accepted Answer

Comparability

Answer

Accuracy

Answer

Validity

Answer

Sensitivity

Question 9

What is the most significant indicator of fertility?

Accepted Answer

Net reproductive rate

Answer

Family size

Answer

Gross reproduction rate

Answer

General fertility rate

Question 10

What is the analysis of routine measurements aimed at detecting changes in the environment known as?

Accepted Answer

Monitoring

Answer

Surveillance

Answer

Isolation

Answer

Randomized Controlled Trial

Epidemiology — MCQs

Epidemiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?